Retinoid-induced expression and activity of an immediate early tumor suppressor gene in vascular smooth muscle cells

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Streb, Jeffrey W ^a   Long, Xiaochun ^a   Lee, Ting Hein ^a   Sun, Qiang ^a   Kitchen, Chad M ^a   Georger, Mary A ^a   Slivano, Orazio J ^a   Blaner, William S ^b   Carr, Daniel W ^c   Gelman, Irwin H ^d   Miano, Joseph M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Howard Hughes Medical Institute   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A KINASE ANCHORING PROTEIN 12BETA; BMS 188649; BMY 46561; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; DACTINOMYCIN; ISOTRETINOIN; RETINOIC ACID; RETINOID DERIVATIVE; TAMIBAROTENE; UNCLASSIFIED DRUG; AKAP12 PROTEIN, RAT; CELL CYCLE PROTEIN; ISOPROTEIN; RETINOID;

ACETYLATION; AKAP12BETA GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY INJURY; CELL GROWTH; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA RESPONSIVE ELEMENT; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RETINOIC ACID RESPONSE ELEMENT; SMOOTH MUSCLE FIBER; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALIA; ATRA; MUS;

A KINASE ANCHOR PROTEINS; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RATS; RESPONSE ELEMENTS; RETINOIDS; TRETINOIN;

EID: 79953707636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018538     Document Type: Article

References (60)

1. Owens GK, Kumar MS, Wamhoff BR, (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
2. Miano JM, Berk BC, (2000) Retinoids: Versatile biological response modifiers of vascular smooth muscle phenotype. Circ Res 87: 355-362.
3. Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK, (1995) Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem 22: 1-10.
4. Streb JW, Miano JM, (2003) Retinoids: pleiotropic agents of therapy for vascular diseases? Current Drug Targets 3: 31-57.
5. Miano JM, Topouzis S, Majesky MW, Olson EN, (1996) Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation 93: 1886-1895.
6. Haxsen V, Adam-Stitah S, Ritz E, Wagner J, (2001) Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells. Circ Res 88: 637-644.
7. Kosaka C, Sasaguri T, Komiyama Y, Takahashi H, (2001) All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases. Hypertens Res 24: 579-588.
8. Pakala R, Benedict CR, (2000) RAR γ agonists inhibit proliferation of vascular smooth muscle cells. J Cardiovasc Pharmacol 35: 302-308.
9. Wang S, Wright G, Geng W, Wright GL, (1997) Retinol influences contractile function and exerts an anti-proliferative effect on vascular smooth muscle cells through an endothelium-dependent mechanism. Pflugers Arch 434: 669-677.
10. Wright G, Wang S, Bailey G, Reichenbecher V, Wright GL, (1996) Effect of retinoic acid on contractile competence of vascular smooth muscle. Am J Physiol 270: H1363-H1370.
11. Miano JM, Kelly LA, Artacho CA, Nuckolls TA, Piantedosi R, et al. (1998) all-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation 98: 1219-1227.
12. Neuville P, Yan Z, Gidlöf A, Pepper MS, Hansson GK, et al. (1999) Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARα-dependent signaling pathway. Arterioscler Thromb Vasc Biol 19: 1430-1436.
13. DeRose JJ Jr, Madigan J, Umana JP, Prystowsky JH, Nowygrod R, et al. (1999) Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg 7: 633-639.
14. Wiegman PJ, Barry WL, McPherson JA, McNamara CA, Gimple LW, et al. (2000) All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: a favorable effect on vessel remodeling. Arterioscler Thromb Vasc Biol 20: 89-95.
15. Chen J, He B, Zheng D, Zhang S, Liu J, Zhu S, (1999) All-trans retinoic acid reduces intimal thickening after balloon angioplasty in atherosclerotic rabbits. Chin Med J 112: 121-123.
16. Leville CD, Dassow MS, Seabrook GR, Jean-Claude JM, Towne JB, et al. (2000) All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo. J Surg Res 90: 183-190.
17. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, et al. (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8: 856-863.
18. Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, et al. (2005) Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res 97: 1132-1141.
19. Haraguchi G, Suzuki JI, Kosuge H, Ogawa M, Koga N, et al. (2006) A new RXR agonist, HX630, suppresses intimal hyperplasia in a mouse blood flow cessation model. J Mol Cell Cardiol 41: 885-892.
20. McKenna NJ, O'Malley BW, (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474.
21. Chen J, Maltby KM, Miano JM, (2001) A novel retinoid-response gene set in vascular smooth muscle cells. Biochem Biophys Res Comm 281: 475-482.
22. Lin X, Tombler E, Nelson PJ, Ross M, Gelman IH, (1996) A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 271: 28430-28438.
23. Gordon T, Grove B, Loftus J, O'Toole T, McMillian R, et al. (1992) Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. J Clin Invest 90: 992-999.
24. Gelman IH, (2002) The role of SSeCKS/Gravin/AKAP12 scaffolding proteins in the spatiotemporal control of signaling pathways in oncogenesis and development. Front Biosci 7: 1782-1797.
25. Wong W, Scott JD, (2004) AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5: 959-970.
26. Akakura S, Huang C, Nelson PJ, Foster B, Gelman IH, (2008) Loss of the ssecks/gravin/akap12 gene results in prostatic hyperplasia. Cancer Res 68: 5096-5103.
27. Gelman IH, Tombler E, Vargas J Jr, (2000) A role for SSeCKS, a major protein kinase C substrate with tumor suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis. Histochem J 32: 13-26.
28. Coats SR, Covington JW, Su M, Pablon-Pena LM, Eren M, et al. (2000) SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotension II and as potential role in the regulation of PAI-1 gene expression. J Mol Cell Cardiol 32: 2207-2219.
29. Streb JW, Kitchen CM, Gelman IH, Miano JM, (2004) Multiple promoters direct expression of three AKAP12 isoforms with distinct tissue and subcellular distribution profiles. J Biol Chem 279: 56014-56023.
30. Quélo I, Jurdic P, (2000) Differential regulation of the carbonic anhydrase II gene expression by hormonal nuclear receptors in monocytic cells: identification of the retinoic acid response element. Biochem Biophys Res Comm 271: 481-491.
31. Taskén K, Aandahl EM, (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84: 137-167.
32. Choi M-C, Jong H-S, Kim TY, Song S-H, Lee DS, et al. (2004) AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 23: 7095-7103.
33. Korshunov VA, Berk BC, (2003) Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 23: 2185-2191.
34. Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, et al. (2010) Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 52: 2023-2033.
35. Stolle K, Weitkamp B, Rauterberg J, Lorkowski S, Cullen P, (2004) Laser microdissection-based analysis of mRNA expression in human coronary arteries with intimal thickening. J Histochem Cytochem 52: 1511-1518.
36. Liu Y, Gao L, Gelman IH, (2006) SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. BMC Cancer 6.
37. Liu H, Huang X, Wang H, Shen A, Cheng C, (2009) Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line. Brain Res 1265: 1-12.
38. Xia W, Unger P, Miller L, Nelson J, Gelman IH, (2001) The src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 61: 5644-5651.
39. Flotho C, Paulun A, Batz C, Niemeyer CM, (2007) AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 138: 644-650.
40. Jo U, Whang YM, Kim HK, Kim YH, (2006) AKAP12alpha is associated with promoter methylation in lung cancer. Cancer Res Treat 38: 144-151.
41. Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, et al. (1997) Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 7: 775-779.
42. Venance SL, Bennett BM, Pang SC, (1993) Forskolin and isoproterenol effect responses on epidermal growth factor induced DNA synthesis in aortic smooth muscle cells. Can J Physiol Pharmacol 71: 800-805.
43. Indolfi C, Di Lorenzo E, Rapacciuolo A, Stingone AM, Stabile E, et al. (2000) 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. J Am Coll Cardiol 36: 288-293.
44. Tao J, Shumay E, McLaughlin S, Wang H-Y, Malbon CC, (2006) Regulation of AKAP-membrane interactions by calcium. J Biol Chem 281: 23932-23944.
45. Yan X, Walkiewicz M, Carlson J, Leiphon L, Grove B, (2009) Gravin dynamics regulates the subcellular distribution of PKA. Exp Cell Res 315: 1247-1259.
46. Ichiki T, (2006) Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both? Arterioscler Thromb Vasc Biol 26: 449-455.
47. Nagpal S, (2004) Retinoids: inducers of tumor/growth suppressors. J Invest Dermatol 123: xx-xxi.
48. Streb JW, Miano JM, (2005) AKAP12α: an atypical serum response factor-dependent target gene. J Biol Chem 280: 4125-4134.
49. Bu Y, Gelman IH, (2007) v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. J Biol Chem 282: 26725-26739.
50. Long X, Miano JM, (2007) Remote control of gene expression. J Biol Chem 282: 15941-15945.
51. Indolfi C, Stabile E, Coppola C, Gallo A, Perrino C, et al. (2001) Membrane-bound protein kinase A inhibits smooth muscle cell proliferation in vitro and in vivo by amplifying cAMP-protein kinase A signals. Circ Res 88: 319-324.
52. Wang H-Y, Tao J, Shumay E, Malbon CC, (2006) G-protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin). Eur J Cell Biol 85: 643-650.
53. Firulli AB, Han D, Kelly-Roloff L, Koteliansky VE, Schwartz SM, et al. (1998) A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell Dev Biol 34: 217-226.
54. Firulli AB, Miano JM, Bi W, Johnson AD, Casscells W, et al. (1996) Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells: association with the activated phenotype. Circ Res 78: 196-204.
55. Wang D-Z, Chang PS, Wang Z, Sutherland L, Richardson JA, et al. (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862.
56. Chen J, Kitchen CM, Streb JW, Miano JM, (2002) Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 34: 1345-1356.
57. Carr DW, Hausken ZE, Fraser IDC, Stofko-Hahn RE, Scott JD, (1992) Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein: cloning and characterization of the RII-binding domain. J Biol Chem 267: 13376-13382.
58. Sun Q, Chen G, Streb JW, Long X, Yang Y, et al. (2006) Defining the mammalian CArGome. Genome Res 16: 197-207.
59. Kumar A, Lindner V, (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17: 2238-2244.
60. Namimatsu S, Ghazizadeh M, Sugisaki Y, (2005) Reversing the effects of formalin fixation with citraconic anhydride and heat: a universal antigen retrieval method. J Histochem Cytochem 53: 3-11.